JIANGXI BIO's Wholly-Owned Subsidiary Secures Regulatory Approval for Veterinary Tetanus Antitoxin

Stock News

11 hours ago

The company JIANGXI BIO (ASX: 06915) has announced that its wholly-owned subsidiary, Chifeng Boen Pharmaceutical Co., Ltd., has recently obtained the official approval document for its veterinary tetanus antitoxin product.

The veterinary tetanus antitoxin is primarily used for the prevention and treatment of tetanus infections in animals. It works by neutralizing the tetanus toxin, providing passive immunity to animals at risk of infection.

The board of directors believes that securing this approval further enriches the group's product portfolio. This development lays a foundation for the group's continued expansion in the animal health market and is expected to help enhance the group's overall competitiveness and long-term growth potential.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/1131987482"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1131987482\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1131987482?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-03 06:57","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1131987482","market":"other","top_or_hot":-1,"title":"JIANGXI BIO's Wholly-Owned Subsidiary Secures Regulatory Approval for Veterinary Tetanus Antitoxin","media":"Stock News","content":"<p>The company <b>JIANGXI BIO</b> (<b>ASX: 06915</b>) has announced that its wholly-owned subsidiary, Chifeng Boen Pharmaceutical Co., Ltd., has recently obtained the official approval document for its veterinary tetanus antitoxin product.<br><br>\nThe veterinary tetanus antitoxin is primarily used for the prevention and treatment of tetanus infections in animals. It works by neutralizing the tetanus toxin, providing passive immunity to animals at risk of infection.<br><br>\nThe board of directors believes that securing this approval further enriches the group's product portfolio. This development lays a foundation for the group's continued expansion in the animal health market and is expected to help enhance the group's overall competitiveness and long-term growth potential.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>JIANGXI BIO's Wholly-Owned Subsidiary Secures Regulatory Approval for Veterinary Tetanus Antitoxin</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJIANGXI BIO's Wholly-Owned Subsidiary Secures Regulatory Approval for Veterinary Tetanus Antitoxin\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-07-03 06:57</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>The company <b>JIANGXI BIO</b> (<b>ASX: 06915</b>) has announced that its wholly-owned subsidiary, Chifeng Boen Pharmaceutical Co., Ltd., has recently obtained the official approval document for its veterinary tetanus antitoxin product.<br><br>\nThe veterinary tetanus antitoxin is primarily used for the prevention and treatment of tetanus infections in animals. It works by neutralizing the tetanus toxin, providing passive immunity to animals at risk of infection.<br><br>\nThe board of directors believes that securing this approval further enriches the group's product portfolio. This development lays a foundation for the group's continued expansion in the animal health market and is expected to help enhance the group's overall competitiveness and long-term growth potential.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06915","symbol_name":"江西生物","start_time":0,"source_url":"","article_id":"1131987482","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1131987482","pubTimestamp":1783033063,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"The company JIANGXI BIO (ASX: 06915) has announced that its wholly-owned subsidiary, Chifeng Boen Pharmaceutical Co., Ltd., has recently obtained the official approval document for its veterinary...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06915":"江西生物"},"translate_title":"江西生物全资子公司兽用破伤风抗毒素获监管批准","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06915":1},"content_text":"The company JIANGXI BIO (ASX: 06915) has announced that its wholly-owned subsidiary, Chifeng Boen Pharmaceutical Co., Ltd., has recently obtained the official approval document for its veterinary tetanus antitoxin product.\nThe veterinary tetanus antitoxin is primarily used for the prevention and treatment of tetanus infections in animals. It works by neutralizing the tetanus toxin, providing passive immunity to animals at risk of infection.\nThe board of directors believes that securing this approval further enriches the group's product portfolio. This development lays a foundation for the group's continued expansion in the animal health market and is expected to help enhance the group's overall competitiveness and long-term growth potential.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"policyRegulatory","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}